Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06416410
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-09
Brief Title:
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS pG12C Mutation
Sponsor:
Jacobio Pharmaceuticals Co Ltd
Organization:
Jacobio Pharmaceuticals Co Ltd
Organization Data
Organization:
Jacobio Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
JAB-21822-3002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jacobio Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None